Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Telehealth providers in Arizona

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

Telehealth prescribing is allowed in Arizona, including asynchronous care. What Arizona requires of telehealth prescribers and pharmacies, plus listings with their verification status.

Arizona at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Telehealth providers serving Arizona

Bodybuilding Peptides

Sponsored

Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.

Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Arizona (not yet confirmed)

  • Prescription only, no research-use-only sales
  • Public cancellation and refund policy

We may earn a commission from these links.

Telehealth prescribing rules in Arizona

A.R.S. 36-3601 defines telehealth as the interactive use of audio, video or other electronic media, including asynchronous store-and-forward technologies and remote patient monitoring, and excludes fax, instant messages, voicemail and email. A.R.S. 36-3602 requires informed consent before telehealth care and bars any health care board from requiring an in-person examination before a prescription is issued, except that Schedule II drugs may be prescribed only after an in-person or audio-visual examination. For physicians, A.R.S. 32-1401(27)(tt) makes it unprofessional conduct to prescribe without first conducting a physical or mental health status examination or having an established relationship, and says that examination may be conducted through telehealth as defined in section 36-3601 with a clinical evaluation appropriate for the patient and the condition. Under A.R.S. 36-3606 a provider licensed in another state may treat Arizona patients by telehealth after registering with the comparable Arizona board, provided the license is unrestricted, the provider carries liability coverage, follows Arizona prescribing law, and registers with the prescription monitoring program before prescribing a controlled substance. Peptides in this database are not controlled. The statutes do not mention online questionnaires. This record classifies asynchronous prescribing as allowed because the statutory telehealth definition expressly includes asynchronous store-and-forward technologies and the physician practice act lets the examination required before prescribing be done through telehealth as so defined. An exchange by email or instant message alone does not count as telehealth. [4] [5] [6] [7]

Compounded GLP-1 access in Arizona

Arizona patients using telehealth GLP-1 programs should confirm that the prescriber is Arizona-licensed or registered under A.R.S. 36-3606 and that the dispensing pharmacy holds an Arizona nonresident permit. [3] [7] [9]

Research use only sellers in Arizona

A.R.S. 32-1931 and rule R4-23-607 prohibit a nonresident from selling or distributing prescription-only drugs into Arizona without a Board nonresident permit, and "research use only" peptides marketed for injection are unapproved new drugs under 21 U.S.C. 331 regardless of labeling. [3] [10]

How to check a telehealth provider in Arizona

  1. Confirm the prescriber is licensed or registered to treat patients located in Arizona; the telehealth rules above explain what Arizona requires. [4] [5] [6] [7]
  2. Ask which pharmacy will fill the prescription and check it in the Arizona State Board of Pharmacy license lookup. [1] [2] [3] [8]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Arizona. [3] [10]

Common questions in Arizona

Can I get a GLP-1 prescription in Arizona through telehealth without seeing a doctor in person?

Yes. A.R.S. 36-3602(E) bars Arizona health care boards from requiring an in-person examination before a prescription is issued, except for Schedule II drugs and where federal law requires one, and the definition of telehealth in A.R.S. 36-3601 includes asynchronous store-and-forward technologies. An Arizona-licensed or Arizona-registered provider may evaluate you remotely and prescribe semaglutide or tirzepatide, which are not controlled substances. An exchange by email or instant message alone does not count as telehealth. [5] [6] [7]

Can an out-of-state telehealth provider treat me in Arizona without an Arizona license?

Yes, if the provider has registered with the relevant Arizona licensing board under A.R.S. 36-3606, holds an unrestricted license in another state, carries liability coverage, and follows Arizona prescribing rules. Registered providers cannot open an Arizona office unless they are part of a multistate provider group that includes at least one Arizona-licensed provider. Check the board's registration list before paying. [7]

Is it legal to buy research peptides online and ship them to Arizona?

No. Distributing prescription-only drugs into Arizona without a nonresident permit violates A.R.S. 32-1931, and "research use only" peptides sold for injection are unapproved drugs under federal law. They are not dispensed by a pharmacist. [3] [10]

All peptide legal questions for Arizona

Sources

  1. [1]Arizona State Board of Pharmacy
  2. [2]Arizona Administrative Code R4-23-410, Current good compounding practices
  3. [3]Arizona Administrative Code R4-23-607, Nonresident permits (implementing A.R.S. 32-1931)
  4. [4]Arizona Revised Statutes 32-1401, Definitions (paragraph 27(tt), examination before prescribing may be conducted through telehealth), accessed 2026-09-30
  5. [5]Arizona Revised Statutes 36-3601, Definitions (telehealth includes asynchronous store-and-forward technologies), accessed 2026-09-30
  6. [6]Arizona Revised Statutes 36-3602, Delivery of health care through telehealth; requirements; exceptions
  7. [7]Arizona Revised Statutes 36-3606, Interstate telehealth services; registration; requirements
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts